Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PTCH1 contributors: mct/npt - updated : 21-10-2018
HGNC name patched homolog 1 (Drosophila)
HGNC id 9585
Corresponding disease
DEL9Q22 chromosome 9q22.3 microdeletion syndrome
HPE7 holoprosencephaly
NBCCS2 nevoid basal cell carcinoma syndrome
Location 9q22.32      Physical location : 98.205.265 - 98.279.247
Synonym name
  • patched homolog (Drosophila)
  • PTCH protein +12b
  • PTCH protein +4'
  • PTCH protein -10
  • patched homolog 1 splice variant 1C
  • Synonym symbol(s) BCNS, PTC, PTC1, PTCH, NBCCS, FLJ26746, FLJ42602, HPE7, TSG9D, PTCH11
    DNA
    TYPE functioning gene
    STRUCTURE 74.00 kb     24 Exon(s)
    regulatory sequence Promoter
    alternative promoter
    motif repetitive sequence   triplet
    text structure
  • six first exons (1a, 1a', 1b,1c,1c', 1d, 1e )
  • CGG triplet repeat located 4 bp upstream of the first methionine codon, in the 5' UTR
  • only one of two putative Gli-binding sites identified in the promoter region is functional, and the transactivating Gli proteins, GLI1, GLI2 and GLI3, bind and enhance transcription through this site
  • three ZNF431 binding sites in the promoter
  • MAPPING cloned Y linked N status confirmed
    Map see NBCCS
    RNA
    TRANSCRIPTS type messenger
    text
  • regulated by three independent promoters generating transcripts with alternative first exons
  • an alternative exon, exon 12b, located between exon 12 and 13 having an in-frame stop codon, the mRNA isoform containing this exon (Patched12b) encodes a truncated patched-1 protein
  • identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    24 splicing 7911 - 1446 colon, testis -
  • exon 1a
  • variant a prime or PTCHl2
  • - splicing - - - specifically upregulated in nodular BCCs -
    inhibiting SMO activity.
    24 splicing 7957 160.5 1447 colon, testis, brain, ovary -
  • exon 1b, variant 1b or PTCHl
  • methylated in some cases of medulloblastoma
  • 24 splicing 7675 - 1295 - -
  • exon 1c, variant 1c or PTCHs
  • N-terminally truncated lacking the first transmembrane domain
  • exon 1c transcription is upregulated by HH signaling, but the resulting PTCH1-1C protein has a lower capacity for pathway inhibition than PTCH1-1B
  • 24 splicing 7658 - 1295 - -
  • exon 1c', variant c prime or PTCHs
  • N-terminally truncated lacking the first transmembrane domain
  • 24 splicing 7831 - 1295 - -
  • exon 1e, variant 1e or PTCHs
  • N-terminally truncated lacking the first transmembrane domain
  • 24 splicing 8065 - 1381 - -
    exon 1a', variant a' ou PTCH2
    24 splicing 7757 - 1295 widely -
    exon 1d, variant 1d or PTCHs
    - splicing 879 - 106 expressed in some of the medulloblastoma tissues and cell lines -
  • exon 1-5, exon 10 and exon 12b specfically expressed in brain and heart, especially in cerebellum
  • having a dominant negative effect on PATCH1
  • important role in the pathogenesis of medulloblastoma as well as brain development
  • EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Digestiveintestinelarge intestinecolon highly
    Hearing/Equilibriumear   highly
    Nervousbrainhindbraincerebellum   Rattus norvegicusFetal
     brainhindbraincerebellum   Rattus norvegicusAdult
     brainlimbic systemhippocampus highly Rattus norvegicusAdult
     brainlimbic systemhippocampus highly Rattus norvegicusFetal
    Respiratorylung   moderately
    Urinarykidney    
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal  
    cells
    SystemCellPubmedSpeciesStageRna symbol
    Nervousneuron Rattus norvegicus
    NervousPurkinje cell Rattus norvegicus
    Reproductivespermatocyte Homo sapiens
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    physiological period embryo, pregnancy
    Text ventral neural tube, somites, limb bud, placenta
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • N and C cytoplasmic termini
  • twelve membrane spanning segments, five of them (TM2 to TM6) forming a sterol sensing domain(SSD)
  • a proline-rich motif in the C terminal region
  • two large hydrophilic extracellular loops
  • two functional GLI-binding sequences
  • conjugated GlycoP
    HOMOLOGY
    interspecies homolog to Drosophila segment polarity gene patched (PTC)
    Homologene
    FAMILY
  • patched family
  • CATEGORY signaling , receptor
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,Golgi
    intracellular,cytoplasm,cytoskeleton,microtubule
    text localization to primary cilia
    basic FUNCTION
  • repressing SMO activity in the absence of SHH
  • involved in endocytosis and vesicle transport
  • playing a role in the development of basal cell cancer
  • regulates hedgehog signaling at the primary cilium, inhibiting the Hh pathway by excluding SMOH and also allows cilia to function as chemosensors for the detection of extracellular SHH
  • PTCH1 and SMO are present in the processes and growth cones of immature neurons
  • key regulator of embryonic development, acting through the sonic hedgehog (SHH) signaling pathway
  • also acts as a lineage-dependent oncogene
  • essential role for ligand-dependent feedback inhibition of vertebrate HH signaling governed collectively by PTCH1, PTCH2 and HHIP
  • PTCH1 and PTCH2 co-operate in regulating cellular responses to SHH
  • PTCH1/PTCH2 mediate likely secretion of a SMO-inhibitory cholesterol precursor
  • PTCH1 and the integral membrane protein 2A (ITM2A) inhibit autophagy by reducing autolysosome formation
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS development
    text embryonic patterning
    PATHWAY
    metabolism
    signaling signal transduction
    GLI1 and PTCH1 are both components and transcriptional targets of the SHH pathway
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • receptor for SHH signaling proteins (negative regulator of the HH-signaling pathway by repressing downstream signaling by the coreceptor smoothened (SMOH))
  • regulator of HH (role of splicing variation and promoter choice for HH signaling regulation)
  • interacting with SCUBE2
  • Sertoli cells coordinate DHH-dependent spermatogenesis events via PTCH1 and SMO prior to the first meiotic division and in postmeiotic (haploid) cells, particularly during the first half of spermiogenesis
  • GPC5 binds to both Hh and PTCH1 through its glycosaminoglycan chains)
  • direct transcriptional target of ZNF431
  • PTCH1 intracellular domain (ICD7) interacted with most components of the CUL2 (CUL2)-based E3 ligase complex, including ELOC, ELOB, ZYG11B, and CUL2 itself
  • PTCH1 is a novel CHL1-binding protein and CHL1 interacts with the first extracellular loop of PTCH1 via its extracellular domain
  • HH reciprocally controls trafficking of SMO and PTC through the SMURF family of E3 ubiquitin ligases
  • inactivation of PTCH1 by HH likely allows a transmembrane sterol to access this seven-transmembrane site (potentially through a hydrophobic tunnel), which drives the activation of SMO
  • cell & other
    REGULATION
    activated by hedgehog proteins (transcriptional activation mediated via the HH-signaling pathway is dependent on the single functional Gli-binding site)
    inhibited by SHH by binding to it at the cilium and inducing its internalization, degradationor movements to other regions of the plasma membrane
    Other regulated by GLI transcription factor
    ASSOCIATED DISORDERS
    corresponding disease(s) NBCCS2 , HPE7 , DEL9Q22 , DEL9Q223
    related resource PTCH Mutation Database
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral somatic mutation      
    in desmoplastic medulloblastoma and in basal cells carcinoma
    tumoral       loss of function
    in medulloblastoma and skin tumors
    tumoral somatic mutation      
    in basal cell carcinoma (BCC) of the skin
    tumoral   LOH    
    in ovarian tumors, benign or malignant, sporadic basal cell carcinoma, small cell lung carcinoma, lymph node metastasis of primary breast cancer
    tumoral   deletion    
    in papillary thyroid carcinoma, in trichoepithelioma, sebaceous nevus, non-melanoma skin cancer, basal cell carcinoma
    tumoral germinal mutation      
    in bladder carcinoma
    tumoral somatic mutation      
    in keratocystic odontogenic tumors
    constitutional   amplification    
    duplication in a family with microcephaly and mild developmental delay
    tumoral   LOH    
    in nonsyndromic or sporadic cardiac fibroma
    tumoral     --other  
    aberrant methylation of the PTCH1 promoter may be an early, initiating event of colon carcinogenesis
    constitutional       loss of function
    concomitant loss of PTCH1 and PTCH2 activity inhibits epidermal lineage specification and differentiation
    Susceptibility to basal cells carcinoma
    Variant & Polymorphism SNP , insertion/deletion , other increasing the risk of basal cells carcinoma
    Candidate gene
  • in a mouse model, APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome (;
  • for Wilms tumor in del 9q22 patients
  • Marker
  • alterations of FANCC and PTCH1 could be used as molecular marker for early diagnosis and prognosis of head and neck squamous cell carcinoma (HNSCC)
  • Therapy target
    ANIMAL & CELL MODELS
  • inhibition of Shh signaling pathway exacerbated rat ischemic damage caused by permanent middle cerebral artery occlusion, which may be correlated with down-regulated expression of Gli1, Ptch1 and Sod1
  • inactivation of Ptch1 in mice leads to formation of gastrointestinal stromal tumor-like tumors that express Pdgfr&
  • 945;, but not Kit